USFDA Flags 11 Observations at Granules’ Gagillapur Plant
The USFDA issued a Form 483 with 11 observations to Granules India’s Gagillapur finished dosage plant, its first inspection since the February 2025 Warning Letter; the company says supply is unaffected.
